Applying gases for microcirculatory and cellular oxygenation in sepsis: Effects of nitric oxide, carbon monoxide, and hydrogen sulfide

Current Opinion in Anaesthesiology

Volumn 22, Issue 2, 2009, Pages 168-176

  Baumgart, Katja ^a   Radermacher, Peter ^a   Wagner, Florian ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Carbon monoxide; Hydrogen sulfide; Microcirculatory blood flow; Mitochondrial respiration; Nitric oxide; Sepsis; Suspended animation; Tissue oxygenation

Indexed keywords

CARBON MONOXIDE; CYTOCHROME C OXIDASE; GLYCERYL TRINITRATE; HYDROGEN SULFIDE; LINSIDOMINE; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADRENERGIC SYSTEM; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BLOOD FLOW; CELL PROTECTION; CELL RESPIRATION; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTINUOUS INFUSION; CYTOTOXICITY; DONOR; HIBERNATION; HUMAN; METABOLISM; MICROCIRCULATION; MOLECULE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEPTIC SHOCK; SHOCK; TISSUE OXYGENATION; UNSPECIFIED SIDE EFFECT;

ANIMALS; CARBON MONOXIDE; HYDROGEN SULFIDE; MICROCIRCULATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXYGEN CONSUMPTION; SEPSIS; SHOCK;

EID: 68049092062     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328328d22f     Document Type: Review

References (104)

1. 2S-donating molecules.
2. 2S be the third endogenous gaseous transmitter? FASEB J 2002; 16:1792-1798.
3. Teodoro RO, O'Farrell PH. Nitric oxide-induced suspended animation promotes survival during hypoxia. EMBO J 2003; 22:580-587.
4. Nystul TG, Roth MB. Carbon monoxide-induced suspended animation protects against hypoxic damage in Caenorhabditis elegans. Proc Natl Acad Sci U S A 2004; 101:9133-9136.
5. 2S induces a suspended animation-like state in mice. Science 2005; 308:518.
6. Vincent JL, Zhang H, Szabó C, Preiser JC. Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 2000; 161:1781-1785.
7. López A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004; 32: 21-30.
8. Groeneveld AB, Sipkema P. Interaction of oxyradicals, antioxidants, and nitric oxide during sepsis. Crit Care Med 2000; 28:2161-2162.
9. Ince C. The microcirculation is the motor of sepsis. Crit Care 2005; 9 (Suppl 4): S13-S19.
10. Trzeciak S, Cinel I, Phillip DR, et al. Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med 2008; 15: 399-413. An elegant review on the crucial role of nitric oxide in the derangement of microvascular perfusion during early sepsis.
11. Lamontagne F, Meade M, Ondiveeran HK, et al. Nitric oxide donors in sepsis: a systematic review of clinical and in vivo preclinical data. Shock 2008; 30:653-659. A concise review of the data available on the use of nitric oxide-donating molecules during shock states.
12. Assadi A, Desebbe O, Kaminski C, et al. Effects of sodium nitroprusside on splanchnic microcirculation in a resuscitated porcine model of septic shock. Br J Anaesth 2008; 100:55-65.
13. 2 gap in experimental endotoxemia: an animal study. Acta Anaesthesiol Scand 2007; 51:693-700.
14. Spronk PE, Ince C, Gardien MJ, et al. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002; 360:1395-1396.
15. Nagasaka Y, Fernandez BO, Garcia-Saura MF, et al. Brief periods of nitric oxide inhalation protect against myocardial ischemia-reperfusion injury. Anesthesiology 2008; 109:675-682. An elegant experimental proof that inhaled nitric oxide may have marked systemic effects as a cardioprotective drug.
16. Cannon RO III, Schechter AN, Panza JA, et al. Effects of inhaled nitric oxide on regional blood flow with intravascular nitric oxide delivery. J Clin Invest 2001; 108:279-287.
17. Kostler WJ, Rabitsch W, Locker GJ, et al. Influence of inhaled nitric oxide on plasma nitrate concentrations in patients with adult respiratory distress syndrome and sepsis: results of a pilot study. J Clin Anesth 2006; 18: 179-184.
18. Cooper CE, Brown GC. The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance. J Bioenerg Biomembr 2008; 40:533-539. An elegant and concise review on the effects of endogenous gaseous mediators on cytochrome-c-oxidase.
19. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360:219-223.
20. Brealey D, Karyampudi S, Jacques TS, et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 2004; 286:R491-R497.
21. Boulos M, Astiz ME, Barua RS, Osman M. Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly(ADP-ribose) synthase. Crit Care Med 2003; 31:353-358.
22. Singer M, De Santis V, Vitale D, Jeffcoate W. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004; 364:545-548.
23. 2S-related therapies targeting mitochondrial respiration during sepsis.
24. 2 uptake and energy metabolism during resuscitated septic shock.
25. Preiser JC, De Backer D. Novel insights into the effects of inducible nitric oxide synthase inhibition during sepsis. Crit Care Med 2008; 36:359-360.
26. Clerc P, Rigoulet M, Leverve X, Fontaine E. Nitric oxide increases oxidative phosphorylation efficiency. J Bioenerg Biomembr 2007; 39:158-166. A sophisticated biochemistry study showing that an nitric oxide-related fall in overall mitochondrial activity is associated with an increased yield of the respiratory chain.
27. Hollenberg SM, Broussard M, Osman J, Parrillo JE. Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circ Res 2000; 86:774-778.
28. Hollenberg SM, Guglielmi M, Parrillo JE. Discordance between microvascular permeability and leukocyte dynamics in septic inducible nitric oxide synthase deficient mice. Crit Care 2007; 11:R125.
29. Barth E, Radermacher P, Thiemermann C, et al. Role of inducible nitric oxide synthase in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock. Crit Care Med 2006; 34:307-313.
30. Albuszies G, Vogt J, Wachter U, et al. The effect of iNOS deletion on hepatic gluconeogenesis in hyperdynamic murine septic shock. Intensive Care Med 2007; 33:1094-1101. Two subsequent reports on well resuscitated ventilated mice with polymicrobial septic shock showing the crucial role of iNOS for myocardial function (ref. [28]) and hepatic metabolic capacity (ref. [29]).
31. Pullamsetti SS, Maring D, Ghofrani HA, et al. Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock. Thromb Haemost 2006; 95:720-727.
32. Hauser B, Bracht H, Matejovic M, et al. Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies. Anesth Analg 2005; 101:488-498.
33. 2-exchange and energy metabolism during hyperdynamic porcine endotoxemia. Shock 2001; 16:203-210.
34. Enkhbaatar P, Murakami K, Traber LD, et al. The inhibition of inducible nitric oxide synthase in ovine sepsis model. Shock 2006; 25:522-527.
35. Westphal M, Enkhbaatar P, Schmalstieg FC, et al. Neuronal nitric oxide synthase inhibition attenuates cardiopulmonary dysfunctions after combined burn and smoke inhalation injury in sheep. Crit Care Med 2008; 36:1196-1204.
36. Maybauer DM, Maybauer MO, Szabó C, et al. Lung-protective effects of the metalloporphyrinic peroxynitrite decomposition catalyst WW-85 in interleukin-2 induced toxicity. Biochem Biophys Res Commun 2008; 377: 786-791.
37. Matejovic M, Krouzecky A, Martinkova V, et al. Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia. Shock 2004; 21:458-465.
38. •]), which shows that combining this approach with the intracellular active oxygen radical scavenger tempol is beneficial during well resuscitated porcine P. aeruginosa bacteremia.
39. Matejovic M, Krouzecky A, Radej J, et al. Coagulation and endothelial dysfunction during longterm hyperdynamic porcine bacteremia - effects of selective inducible nitric oxide synthase inhibition. Thromb Haemost 2007; 97:304-309. The second paper originating from a clinically relevant, long-term porcine experiment (see also [37]), which elegantly demonstrates the therapeutic benefit of selective iNOS inhibition using a posttreatment approach during well resuscitated P. aeruginosa bacteremia.
40. Germann P, Braschi A, Della Rocca G, et al. Inhaled nitric oxide therapy in adults: European expert recommendations. Intensive Care Med 2005; 31:1029-1041.
41. •]) on the efficacy of inhaled nitric oxide.
42. Evgenov OV, Busch CJ, Evgenov NV, et al. Inhibition of phosphodiesterase 1 augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs with acute pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2006; 290:L723-L729.
43. •]) on the efficacy of inhaled nitric oxide.
44. Busch T, Petersen B, Deja M, et al. Endothelin-1 influences the efficacy of inhaled nitric oxide in experimental acute lung injury. Exp Biol Med (Maywood) 2006; 231:974-978.
45. •]) on the efficacy of inhaled nitric oxide.
46. McClintock DE, Ware LB, Eisner MD, et al. Higher urine nitric oxide is associated with improved outcomes in patients with acute lung injury. Am J Respir Crit Care Med 2007; 175:256-262. A nice observational study highlighting the putative impact of endogenous nitric oxide production during acute lung injury.
47. G-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 h can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit Care Med 2004; 32:1-12.
48. G-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit Care Med 2004; 32:13-20.
49. Phillip Dellinger R, Parrillo JE. Mediator modulation therapy of severe sepsis and septic shock: does it work? Crit Care Med 2004; 32:282-286.
50. Alonso JR, Caredellach F, López S, et al. Carbon monoxide specifically inhibits cytochrome c oxidase of human mitochondrial respiratory chain. Pharmacol Toxicol 2003; 93:142-146.
51. Foresti R, Bani-Hani MG, Motterlini R. Use of carbon monoxide as a therapeutic agent: promises and challenges. Intensive Care Med 2008; 34:649-658. The first part of two elegant subsequent review articles on the biochemistry, pharmacology, and therapeutic potential of manipulating the heme oxygenase system and carbon monoxide.
52. Bauer M, Huse K, Settmacher U, Claus RA. The heme oxygenase-carbon monoxide system: regulation and role in stress response and organ failure. Intensive Care Med 2008; 34:640-648. The second part of two elegant subsequent review articles on the biochemistry, pharmacology, and therapeutic potential of manipulating the heme oxygenase system and carbon monoxide.
53. Piantadosi CA. Carbon monoxide, reactive oxygen signaling, and oxidative stress. Free Radic Biol Med 2008; 45:562-569.
54. Gröger M, Speit G, Radermacher P, Muth CM. Interaction of hyperbaric oxygen, nitric oxide, and heme oxygenase on DNA strand breaks in vivo. Mutat Res 2005; 572:167-172.
55. Zuckerbraun BS, McCloskey CA, Gallo D, et al. Carbon monoxide prevents multiple organ injury in a model of hemorrhagic shock and resuscitation. Shock 2005; 23:527-532.
56. Zuckerbraun BS, Otterbein LE, Boyle P, et al. Carbon monoxide protects against the development of experimental necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2005; 289:G607-G613.
57. Clark JE, Naughton P, Shurey S, et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 2003; 93:e2-e8.
58. Guo Y, Stein AB, Wu WJ, et al. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 2004; 286:H1649-H1653.
59. Stein AB, Guo Y, Tan W, et al. Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol 2005; 38:127-134.
60. Cepinskas G, Katada K, Bihari A, Potter RF. Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. Am J Physiol Gastrointest Liver Physiol 2008; 294:G184-G191.
61. Zuckerbraun BS, Chin BY, Bilban M, et al. Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species. FASEB J 2007; 21:1099-1106.
62. Rensing H, Jaeschke H, Bauer I, et al. Differential activation pattern of redoxsensitive transcription factors and stress-inducible dilator systems heme oxygenase-1 and inducible nitric oxide synthase in hemorrhagic and endotoxic shock. Crit Care Med 2001; 29:1962-1971.
63. Foresti R, Motterlini R. The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homoeostasis. Free Rad Res 1999; 31:459-475.
64. Hoetzel A, Welle A, Schmidt R, et al. Nitric oxide-deficiency regulates hepatic heme oxygenase-1. Nitric Oxide 2008; 18:61-69. An elegant experimental study demonstrating the impact of endogenous nitric oxide and carbon monoxide release on the hepatic arterial and portal venous vascular bed.
65. Nalos M, Vassilev D, Pittner A, et al. Sn-mesoporphyrin to inhibit heme oxygenase during long-term hyperdynamic porcine endotoxemia. Shock 2003; 19:526-532.
66. Zuckerbraun BS, Chin BY, Wegiel B, et al. Carbon monoxide reverses established pulmonary hypertension. J Exp Med 2006; 203:2109-2119.
67. Herrera EA, Reyes RV, Giussani DA, et al. Carbon monoxide: a novel pulmonary artery vasodilator in neonatal llamas of the Andean altiplano. Cardiovasc Res 2008; 77:197-201.
68. Hangai-Hoger N, Tsai AG, Cabrales P, et al. Microvascular and systemic effects following top load administration of saturated carbon monoxide-saline solution. Crit Care Med 2007; 35:1123-1132.
69. Pannen BH, Bauer M. Differential regulation of hepatic arterial and portal venous vascular resistance by nitric oxide and carbon monoxide in rats. Life Sci 1998; 62:2025-2033.
70. Moore BA, Overhaus M, Whitcomb J, et al. Brief inhalation of low-dose carbon monoxide protects rodents and swine from postoperative ileus. Crit Care Med 2005; 33:1317-1326.
71. Wunder C, Brock RW, Frantz S, et al. Carbon monoxide, but not endothelin-1, plays a major role for the hepatic microcirculation in a murine model of early systemic inflammation. Crit Care Med 2005; 33:2323-2331.
72. Schmidt R, Tritschler E, Hoetzel A, et al. Heme oxygenase-1 induction by the clinically used anesthetic isoflurane protects rat livers from ischemia/reperfusion injury. Ann Surg 2007; 245:931-942.
73. Åberg AM, Abrahamsson P, Johansson G, et al. Does carbon monoxide treatment alter cytokine levels after endotoxin infusion in pigs? A randomized controlled study. J Inflamm (Lond) 2008; 5:13.
74. Goebel U, Siepe M, Mecklenburg A, et al. Carbon monoxide inhalation reduces pulmonary inflammatory response during cardiopulmonary bypass in pigs. Anesthesiology 2008; 108:1025-1036. An elegant and sophisticated proof of the anti-inflammatory potential of inhaled carbon monoxide in a clinically relevant porcine model of cardiac surgery.
75. Lavitrano M, Smolenski RT, Musumeci A, et al. Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs. FASEB J 2004; 18:1093-1095.
76. Mazzola S, Forni M, Albertini M, et al. Carbon monoxide pretreatment prevents respiratory derangement and ameliorates hyperacute endotoxic shock in pigs. FASEB J 2005; 19:2045-2047.
77. Zegdi R, Perrin D, Burdin M, et al. Increased endogenous carbon monoxide production in severe sepsis. Intensive Care Med 2002; 28:793-796.
78. Melley DD, Finney SJ, Elia A, et al. Arterial carboxyhemoglobin level and outcome in critically ill patients. Crit Care Med 2007; 35:1882-1887. An important observational study suggesting that there is an optimal endogenous heme oxygenase activity below and beyond which endogenous carbon monoxide production may be deleterious.
79. Mayr FB, Spiel A, Leitner J, et al. Effects of carbon monoxide inhalation during experimental endotoxemia in humans. Am J Respir Crit Care Med 2005; 171:354-360.
80. Mok YY, Atan MS, Yoke Ping C, et al. Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br J Pharmacol 2004; 143:881-889.
81. 2S may protect against lethal hemorrhage.
82. Sivarajah A, McDonald MC, Thiemermann C. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock 2006; 26:154-161.
83. ATP channels. Basic Res Cardiol 2006; 101:53-60.
84. 2S during myocardial ischemia-reperfusion injury as a result of preserved mitochondrial function and, consequently, attenuated tissue acidosis.
85. Jha S, Calvert JW, Duranski MR, et al. Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signalling. Am J Physiol Heart Circ Physiol 2008; 295:H801-H806.
86. Sodha NR, Clements RT, Feng J, et al. The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg 2008; 33:906-913. A nice experiment extending the data from ref. [83] to a clinically relevant porcine model of cardiac surgery.
87. Fu Z, Liu X, Geng B, et al. Hydrogen sulfide protects rat lung from ischemia-reperfusion injury. Life Sci 2008; 82:1196-1202.
88. 2S in a clinically relevant large animal model.
89. Sivarajah A, Collino M, Yasin M, et al. Antiapoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock 2008 [Epub ahead of print]. doi: 10.1097/SHK. 0b013e318180ff89.
90. Tripatara P, Sa PN, Collino M, et al. Generation of endogenous hydrogen sulfide by cystathionine-γ-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest 2008; 88:1038-1048.
91. Zhang H, Zhi L, Moore PK, Bhatia M. Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol 2006; 290:L1193-L1201.
92. Zhang H, Zhi L, Moochhala S, et al. Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-κB. Am J Physiol Lung Cell Mol Physiol 2007; 292:L960-L971.
93. 2S during burn and smoke inhalation-induced acute lung injury.
94. Tamizhselvi R, Moore PK, Bhatia M. Inhibition of hydrogen sulfide synthesis attenuates chemokine production and protects mice against acute pancreatitis and associated lung injury. Pancreas 2008; 36:e24-e31.
95. Whiteman M, Armstrong JS, Chu SH, et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? J Neurochem 2004; 90:765-768.
96. Dorman DC, Moulin FJM, McManus BE, et al. Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentrations in the rat brain, liver, lung, and nasal epithelium. Toxicol Sci 2002; 65:18-25.
97. 2S-induced suspended animation in spontaneously breathing mice.
98. Li J, Zhang G, Cai S, Redington AN. Effect of inhaled hydrogen sulfide on metabolic responses in anesthetized, paralyzed, and mechanically ventilated piglets. Pediatr Crit Care Med 2008; 9:110-112.
99. 2S induced hypometabolism in mice is missing in sedated sheep. Respir Physiol Neurobiol 2008; 160:109-115.
100. Levy RJ, Piel DA, Acton PD, et al. Evidence of myocardial hibernation in the septic heart. Crit Care Med 2005; 33:2752-2756.
101. 2S-induced suspended animation protects against otherwise lethal hypoxia.
102. Li L, Bhatia M, Moore PK. Hydrogen sulphide - a novel mediator of inflammation. Curr Opin Pharmacol 2006; 6:125-129.
103. Remick DG, Xioa H. Hypothermia and sepsis. Front Biosci 2006; 11:1006-1013.
104. L'Her E, Amerand A, Vettier A, Sebert P. Effects of mild induced hypothermia during experimental sepsis. Crit Care Med 2006; 34:2621-2623.